UBS Maintains Buy on Elevance Health, Raises Price Target to $605

benzinga_article
2024.04.19 14:32

瑞銀分析師 A.J. Rice 維持對 Elevance Health（紐交所：ELV）的買入評級，並將目標股價從 585 美元上調至 605 美元

瑞銀分析師 A.J. Rice 維持對 Elevance Health（紐約證券交易所：ELV）的買入評級，並將目標股價從 585 美元上調至 605 美元

Source: benzinga_article The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.